Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors

53Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Ten oxazoles bearing a C(4) carboxyl group were synthesized and evaluated as transthyretin (TTR) amyloid fibril inhibitors. Substituting aryls at the C(2) position of the oxazole ring reveals that a 3,5-dichlorophenyl substituent significantly reduced amyloidogenesis. The efficacy of these inhibitors was enhanced further by installing an ethyl, a propyl, or a CF3 group at the C(5) position. The CF3 substitution at C(5) also improves the TTR binding selectivity over all the other proteins in human blood. © 2004 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Razavi, H., Powers, E. T., Purkey, H. E., Adamski-Werner, S. L., Chiang, K. P., Dendle, M. T. A., & Kelly, J. W. (2005). Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors. Bioorganic and Medicinal Chemistry Letters, 15(4), 1075–1078. https://doi.org/10.1016/j.bmcl.2004.12.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free